Piribedil

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

13 competitors in Tinnitus

#DrugCompanyPhaseTrials

1

Levitra

Bayer

Approved

—2

Paxil

SSebela Pharmaceuticals Development LLC

Approved

13

Decadron

AAspen Global Incorporated

Approved

14

Xylocaine

MMEDRx USA, Inc.

Approved

—5

Pletal

Otsuka

Preclinical

16

Rayos

RRoxane Laboratories

Preclinical

17

IV Lidocaine

WWake Forest University Health Sciences

Phase 1

18

Syntocinon

SShana McCormack, MD

Preclinical

19

Nicorette

HHALEON

Preclinical

210

Distilled Water

GSK

Preclinical

1Show 3 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Parkinson's Disease4 trials

SEDPARK2: Post Marketing Surveillance to Observe Safety and Efficacy of Piribedil in Parkinson's Disease (PIR-002/K)

Completed·Roche··NCT00727727·750 enrolled

SEDPARK1: Safety and Efficacy Study With the Non-ergot Dopamine-agonist Piribedil in Parkinson's Disease

Completed·Roche··NCT00725478·250 enrolled

PIRLONG-PD Safety and Efficacy of Piribedil in Parkinson's Disease During Long Term Therapy

Completed·Roche··NCT01519856·908 enrolled

Show 1 more trial

Influence of Piribedil (Clarium®) on Vigilance and Cognitive Function in Patients With Parkinson's Disease Compared to Other Non-Ergot Dopamine Agonists

Completed·Roche·Phase 3·NCT01007864·80 enrolled

Tinnitus1 trial

Tinnitus Treatment With Piribedil Guided by Acoustic Otoemissions and Electrocochleography

Completed·FFaculdade de Medicina de Valenca·N/A·NCT00591994·100 enrolled

Details

Drug Info

Related News